TVTX Stock Summary and Trading Ideas (Travere Therapeutics | NASDAQ:TVTX)

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

What symbol and exchange does Travere Therapeutics shares trade?

Travere Therapeutics trades on the NASDAQ stock market under the symbol TVTX.

What is Travere Therapeutics stock price doing today?

As of September 16, 2026, TVTX stock price climbed to $63.48 with 2,130,566 million shares trading.

What is Travere Therapeutics's Beta?

TVTX has a beta of 1.85, meaning it tends to be more sensitive to market movements. TVTX has a correlation of 0.14 to the broad based SPY ETF.

How much is Travere Therapeutics worth?

TVTX has a market cap of $5.90 billion. This is considered a Mid Cap stock.

How much money does Travere Therapeutics make?

Last quarter Travere Therapeutics reported $170 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $10 million and missed earnings estimates by -$.33.

What is the highest and lowest price Travere Therapeutics traded in the last 3 year period?

In the last 3 years, TVTX traded as high as $68.73 and as low as $5.12.

What are the top ETFs holding Travere Therapeutics?

The top ETF exchange traded funds that TVTX belongs to (by Net Assets): VTI, XBI, VXF, VTWO, SCHA.

Is Travere Therapeutics (TVTX) a good investment?

TVTX has outperformed the market in the last year with a return of +175.9%, while the SPY ETF gained +15.2%. In the last 3 month period, TVTX beat the market returning +18.0%, while SPY returned +0.1%. However, in the most recent 2 weeks TVTX has underperformed the stock market by returning -3.4%, while SPY returned -1.0%.

What are the support and resistance levels for Travere Therapeutics (TVTX)?

TVTX support price is $61.07 and resistance is $63.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TVTX shares will trade within this expected range on the day.